Editorials

Can we better evaluate responses in higher-risk myelodysplastic syndromes?

Université Paris Cité, INSERM UMR 1342, Institut de Recherche Saint-Louis, Paris, France; Leukemia Institute Paris Saint-Louis, Paris, France; Service Hématologie Seniors, Assistance Publique des Hôpitaux de Paris (APHP), Université Paris Cité, Paris
Université Paris Cité, INSERM UMR 1342, Institut de Recherche Saint-Louis, Paris, France; Leukemia Institute Paris Saint-Louis, Paris
Haematologica Early view Oct 29, 2026 https://doi.org/10.3324/haematol.2026.302157